Ligand Pharmaceuticals reported $1.26B in Assets for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Assets Change
Acceleron Pharma XLRN:US $ 836.05M 39.74M
Acorda Therapeutics ACOR:US $ 491.5M 92.55M
Agenus AGEN:US $ 192.3M 42.62M
Amgen AMGN:US $ 59773M 2766M
Anika Therapeutics ANIK:US $ 363.13M 0.88M
Arena Pharmaceuticals ARNA:US $ 1084.66M 99.28M
Arrowhead Research ARWR:US $ 734.93M 21.87M
Baxter International BAX:US $ 19682M 216M
Bristol Myers Squibb BMY:US $ 110797M 1638M
Clovis Oncology CLVS:US $ 572.23M 23.39M
Dicerna Pharmaceuticals DRNA:US $ 838.49M 155.08M
Eli Lilly And LLY:US $ 47809M 970.7M
Enanta Pharmaceuticals ENTA:US $ 450.44M 17.33M
Endo International Ordinary Shares ENDP:US $ 9206.26M 27.91M
Flexion Therapeutics FLXN:US $ 210.05M 20.33M
Gilead Sciences GILD:US $ 67984M 492M
GlaxoSmithKline GSK:LN 77011M 1068M
Glaxosmithkline GSK:US $ 77011M 1068M
Harsco HSC:US $ 3022.1M 31.76M
Heron Therapeutics HRTX:US $ 404.25M 93.32M
Immunogen IMGN:US $ 301.45M 44.52M
Insmed INSM:US $ 1.23B 537.39M
Intrexon XON:US $ 402.57M 4.41M
Karyopharm Therapeutics KPTI:US $ 286.57M 11.66M
Lannett LCI:US $ 683.74M 178.63M
Ligand Pharmaceuticals LGND:US $ 1256.28M 38.84M
Macrogenics MGNX:US $ 425.91M 9.53M
Pacira Pharmaceuticals PCRX:US $ 1325.83M 38.28M
Rigel Pharmaceuticals RIGL:US $ 201.6M 14.4M
Sangamo Biosciences SGMO:US $ 835.36M 41.73M
Spectrum Pharmaceuticals SPPI:US $ 175.04M 3.96M
Teva Pharmaceutical Industries TEVA:US $ 49195M 191M
Veracyte VCYT:US $ 1027.44M 2.3M